Nutex Health Inc. (NASDAQ:NUTX) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC increased its position in Nutex Health Inc. (NASDAQ:NUTX) by 12.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,125 shares of the company’s stock after buying an additional 3,826 shares during the quarter. Geode Capital Management LLC owned about 0.63% of Nutex Health worth $1,082,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in NUTX. American Century Companies Inc. purchased a new position in Nutex Health in the 4th quarter worth approximately $1,362,000. Essex Investment Management Co. LLC raised its stake in shares of Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock valued at $3,353,000 after purchasing an additional 33,024 shares in the last quarter. Truist Financial Corp raised its stake in shares of Nutex Health by 22.2% during the fourth quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock valued at $1,127,000 after purchasing an additional 6,454 shares in the last quarter. Legato Capital Management LLC raised its position in Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock worth $1,004,000 after acquiring an additional 6,697 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft bought a new stake in Nutex Health in the fourth quarter worth about $206,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Stock Up 4.9 %

Shares of NASDAQ:NUTX opened at $109.97 on Thursday. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The company has a market cap of $607.91 million, a PE ratio of -11.72 and a beta of 0.27. Nutex Health Inc. has a 52 week low of $4.16 and a 52 week high of $152.51. The firm has a 50 day simple moving average of $81.56 and a 200 day simple moving average of $51.95.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.

Insider Transactions at Nutex Health

In related news, CFO Jon Christian Bates purchased 1,000 shares of Nutex Health stock in a transaction on Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the acquisition, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 38.52% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Separately, Maxim Group boosted their price objective on Nutex Health from $75.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 8th.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.